Delphi Ventures

Delphi Ventures is a venture capital firm that has focused on investing in biotechnology and medical devices for over two decades. With more than $1.1 billion in committed capital, Delphi Ventures has funded over 170 companies. More than 110 of our portfolio companies have either completed an initial public offering or have been acquired by a leading healthcare corporation.

Delphi Ventures, established in 1988 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity, Seed investments across Biotechnology, Health Care, Biopharma, Financial Services, Venture Capital, Finance, Life Science, Banking, Medical, Medical Device. The organization boasts a portfolio of 201 investments, with an average round size of $23.6M and 45 successful exits. Their recent investments include Relypsa, Mediphase Venture Partners, Sprout Group, 5AM Ventures, New Leaf Venture Partners. The highest investment round they participated in was $403.0B. Among their most notable exits are Relypsa and Mediphase Venture Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.